Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor

被引：0
|
作者：
Surya P. Ayalasomayajula
Thomas H. Langenickel
Pierre Jordaan
Wei Zhou
Priyamvada Chandra
Diego Albrecht
Parasar Pal
Iris Rajman
Gangadhar Sunkara
机构：
[1] Novartis Institutes for BioMedical Research,Drug Metabolism and Pharmacokinetics
[2] Novartis Pharma AG,Translational Medicine, Clinical Pharmacology and Profiling
[3] Novartis Healthcare Pvt Ltd,undefined
来源：
European Journal of Clinical Pharmacology | 2016年 / 72卷
关键词：
Angiotensin receptor neprilysin inhibitor; LCZ696; Pharmacokinetics; Renal impairment; Valsartan; Sacubitril;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1065 / 1073
页数：8
相关论文
共 50 条
  • [21] Angiotensin receptor neprilysin inhibitor LCZ696: a novel targeted therapy for arterial hypertension?
    Katsi, Vasiliki
    Skalis, Georgios
    Pavlidis, Antonis N.
    Makris, Thomas
    Nihoyannopoulos, Petros
    Tousoulis, Dimitris
    Kallikazaros, Ioannis
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2015, 1 (04) : 260 - 264
  • [22] Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction
    Voors, Adriaan A.
    Gori, Mauro
    Liu, Licette C. Y.
    Claggett, Brian
    Zile, Michael R.
    Pieske, Burkert
    McMurray, John J. V.
    Packer, Milton
    Shi, Victor
    Lefkowitz, Martin P.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (05) : 510 - 517
  • [23] Safety profile of novel angiotensin II type-1 receptor neprilysin inhibitor lcz696 (sacubitril/valsartan) - a collaborative summary from clinical trials
    Barano, A. Z.
    Putri, E. N.
    Addai, M. F.
    Abduh, M.
    Ilmasari, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 586 - 587
  • [24] Safety of the neprilysin/renin-angiotensin system inhibitor LCZ696
    Li, Bo
    Zhao, Yunhe
    Yin, Bo
    Helian, Mengfei
    Wang, Xinmei
    Chen, Feng
    Zhang, Hongxia
    Sun, Hui
    Meng, Bin
    An, Fengshuang
    ONCOTARGET, 2017, 8 (47) : 83323 - 83333
  • [25] Renal protective effects and mechanisms of the angiotensin receptor-neprilysin inhibitor LCZ696 in mice with cardiorenal syndrome
    Li, Ying
    Kang, Li
    Rong, Kai
    Zhang, Yue
    Suo, Ya
    Yuan, Meng
    Bao, Qiankun
    Shao, Shuai
    Tse, Gary
    Li, Rong
    Liu, Tong
    Li, Guangping
    LIFE SCIENCES, 2021, 280
  • [26] Angiotensin II receptor Neprilysin inhibitor (LCZ696) compared to Valsartan attenuates Hepatotoxicity in STZ-induced hyperglycemic rats
    Alqahtani, Faleh
    Mohany, Mohamed
    Alasmari, Abdullah F.
    Alanazi, Ahmed Z.
    Belali, Osamah M.
    Ahmed, Mohammed M.
    Al-Rejaie, Salim S.
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (18): : 3098 - 3106
  • [27] Efficacy of LCZ696, an angiotensin receptor neprilysin inhibitor (ARNI), in obese and overweight subjects with hypertension
    Ruilope, L. M.
    Izzo, J. L., Jr.
    Conde, L. G.
    Zappe, D. H.
    Zhang, Y.
    Zhang, J.
    EUROPEAN HEART JOURNAL, 2014, 35 : 65 - 65
  • [28] Pharmacokinetics and safety of sacubitril/valsartan (LCZ696) in patients with mild and moderate hepatic impairment
    Kulmatycki, Kenneth M.
    Langenickel, Thomas
    Ng, Wai Hong
    Pal, Parasar
    Zhou, Wei
    Lin, Tsu-Han
    Rajman, Iris
    Chandra, Priyamvada
    Sunkara, Gangadhar
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (09) : 728 - 739
  • [29] Pharmacokinetic, pharmacodynamic, and antihypertensive effects of the neprilysin inhibitor LCZ-696: sacubitril/valsartan
    Chrysant, Steven G.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2017, 11 (07) : 461 - 468
  • [30] Effect of the angiotensin receptor neprilysin inhibitor LCZ696 compared with enalapril according to age in PARADIGM-HF
    Mcmurray, J. J. V.
    Jhund, P. S.
    Fu, M.
    Katova, T.
    Rouleau, J. L.
    Solomon, S. D.
    Swedberg, K.
    Zile, M.
    Salko, M.
    Packer, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 143 - 143
12345